Tech Company Financing Transactions
InGeneron Funding Round
On 3/7/2017, InGeneron secured $20 million in Series D funding from Sanford Health.
Transaction Overview
Company Name
Announced On
3/7/2017
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series D
Investors
Sanford Health (Kelby Krabbenhoft)
Proceeds Purpose
The funding is in addition to an active cooperation between InGeneron and Sanford Health for the execution of InGeneron's clinical programs to improve outcomes in rotator cuff and venous ulcer treatment with its proprietary cell-based therapeutic approach.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
8205 El Rio St.
Houston, TX 77054
USA
Houston, TX 77054
USA
Phone
Website
Email Address
Overview
We believe regenerative medicine is redefining modern healthcare. Progress in medicine will be driven by the self-healing power of regenerative cells, including stem cells. Our system enables physicians to unlock the regenerative, self-healing power within a patient's body.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Financial Officer
Fabian Alt
Chief Scientific Officer
Glenn Winnier
President
Ron Stubbers
Browse more venture capital transactions:
Prev: 3/7/2017: Lucy venture capital transaction
Next: 3/7/2017: Zolo Technologies venture capital transaction
Share this article
About Database of VC Transactions
We report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs